More than two decades ago, a well‐known study on heart attack treatments provided
evidence suggesting that, when appropriately adjusted for quality, medical care prices were …

The aim of this study was to critically evaluate the quality of the models used in economic
evaluations of screening strategies for cervical cancer prevention. We systematically …

Background As with many high-income countries, vaccination coverage against human
papilloma virus (HPV) infection is not high in New Zealand (NZ) at 47% in school-aged girls …

Background Health economic evaluations of interventions in infectious disease are
commonly based on the predictions of ordinary differential equation (ODE) systems or …

Abstract Background In Norway, pap smear screening target women aged 25–69 years on a
triennial basis. The introduction of human papillomavirus (HPV) mass immunization in 2009 …

Background Doubts exist around the value of compiling league tables for cost-effectiveness
results for health interventions, primarily due to methods differences. We aimed to determine …

O câncer do colo do útero é o quarto tipo de câncer mais frequente em mulheres em todo
mundo. No Brasil, estima-se que cerca de 16 mil novos casos ocorrem por ano. A redução …

BIJLAGE G: KOSTENEFFECTIVITEIT VAN BEVOLKINGSONDERZOEK NAAR
BAARMOEDERHALS-, BORST- EN DIKKEDARMKANKER: EEN SYSTEMATISCHE REVI …

Introduction of human papillomavirus (HPV) vaccination programs raises some important
questions about the future organization of cervical screening programs. Two studies—from …

Cancer of the uterine cervix is still a major cause of young women's mortality, despite more
than a half a century of sustained cytological effort and the launch of the VLP HPV vaccine …